Apr 14, 2022
1:175
For every 175 shares held, investors received 1. The price per share adjusted from $0.00 to $0.00.
The split itself did not change the total investment value.
Zelira Therapeutics Limited (ZLDAF) trades on the Other OTC in the Biotechnology industry.
Zelira Therapeutics Limited company overviewThe latest split shown was on April 14, 2022. It was a 1-for-175 reverse split, so shareholders received 1 share for every 175 they held.
This history records one reverse split, on April 14, 2022.
Already premium? Sign in